Funding of 80 million SEK in 2025 for the Genomic Medicine Sweden (GMS) project

On April 14, 2025, the National Board of Health and Welfare was tasked to allocate 80 million SEK from the government to support Genomic Medicine Sweden (GMS) project in 2025. 

The GMS project was launched in 2018 to enable improved diagnostics, personalized treatment choices, and research in the field of precision medicine through a broad collaboration of the seven regions with university healthcare and the seven universities with medical faculties (Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala and Örebro). GMS also collaborates with clinicians, academia, industry, patient organizations, and other societal stakeholders such as SciLifeLab.

In 2025, the following distribution of funds is planned:

• 4.9 million SEK - for continued work within the BrainChild innovation project;
• 14.5 million SEK - for work on a national implementation project of whole-genome sequencing for rare diseases based on long DNA reads. The funds may also be used for national and international work on precision diagnostics for children with undiagnosed rare diseases with malformations and/or intellectual disabilities;
• 6.3 million SEK - for continued work on national implementation of whole-genome and transcription sequencing for adults with acute leukemias and the development of gene panel analysis for sensitive detection of residual disease;
• 19.5 million SEK - for scaled-up implementation and further development of precision diagnostics (tissue and liquid biopsies) for solid tumors in routine healthcare and clinical studies;
• 4.8 million SEK - for continued work on implementing precision diagnostics in infectious diseases, including detection of antibiotic resistance, as well as for expanded data sharing between regions for detection of outbreaks of antibiotic-resistant bacteria;
• 30 million SEK - for managing the collaborative project that constitutes GMS and promotes the equitable implementation of precision health in the country.

See the full details here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.